Routine Use of a Commercial Test, GLABRATA RTT, for Rapid Identification of Candida glabrata in Six Laboratories
AUTOR(ES)
Freydiere, A. M.
FONTE
American Society for Microbiology
RESUMO
When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=522330Documentos Relacionados
- Comparison of a New Commercial Test, GLABRATA RTT, with a Dipstick Test for Rapid Identification of Candida glabrata
- Rapid Identification of Candida glabrata with a New Commercial Test, GLABRATA RTT
- Identification of Candida glabrata by a 30-Second Trehalase Test
- Comparison of Four Methodologies for Rapid and Cost-Effective Identification of Candida glabrata
- Rapid Identification of Candida dubliniensis with Commercial Yeast Identification Systems